Kanawha Capital Management’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,178
| Closed | -$236K | – | 237 |
|
|
2024
Q2 | $236K | Buy |
2,178
+435
| +25% | +$51.3K | 0.02% | 214 |
|
|
2024
Q1 | $230K | Buy |
+1,743
| New | +$218K | 0.02% | 207 |
|
|
2023
Q4 | – | Sell |
-2,231
| Closed | -$250K | – | 212 |
|
|
2023
Q3 | $250K | Hold |
2,231
| – | – | 0.02% | 189 |
|
|
2023
Q2 | $325K | Sell |
2,231
-133
| -6% | -$18.1K | 0.03% | 176 |
|
|
2023
Q1 | $305K | Sell |
2,364
-197
| -8% | -$24.7K | 0.03% | 182 |
|
|
2022
Q4 | $327K | Sell |
2,561
-150
| -6% | -$17.4K | 0.03% | 173 |
|
|
2022
Q3 | $283K | Sell |
2,711
-246
| -8% | -$27K | 0.03% | 168 |
|
|
2022
Q2 | $311K | Buy |
2,957
+4
| +0.1% | +$475 | 0.03% | 166 |
|
|
2022
Q1 | $378K | Sell |
2,953
-140
| -5% | -$16.9K | 0.03% | 162 |
|
|
2021
Q4 | $382K | Sell |
3,093
-411
| -12% | -$53.8K | 0.03% | 169 |
|
|
2021
Q3 | $498K | Sell |
3,504
-515
| -13% | -$75.8K | 0.05% | 144 |
|
|
2021
Q2 | $628K | Hold |
4,019
| – | – | 0.06% | 132 |
|
|
2021
Q1 | $625K | Hold |
4,019
| – | – | 0.06% | 131 |
|
|
2020
Q4 | $601K | Buy |
4,019
+158
| +4% | +$22.3K | 0.06% | 125 |
|
|
2020
Q3 | $510K | Hold |
3,861
| – | – | 0.06% | 126 |
|
|
2020
Q2 | $447K | Sell |
3,861
-124
| -3% | -$14.3K | 0.06% | 135 |
|
|
2020
Q1 | $391K | Sell |
3,985
-59
| -1% | -$7.73K | 0.06% | 130 |
|
|
2019
Q4 | $588K | Buy |
4,044
+1,119
| +38% | +$154K | 0.07% | 123 |
|
|
2019
Q3 | $390K | Buy |
2,925
+220
| +8% | +$28.4K | 0.05% | 145 |
|
|
2019
Q2 | $309K | Sell |
2,705
-463
| -15% | -$54.2K | 0.04% | 152 |
|
|
2019
Q1 | $393K | Buy |
3,168
+154
| +5% | +$17.5K | 0.06% | 135 |
|
|
2018
Q4 | $303K | Sell |
3,014
-332
| -10% | -$37.3K | 0.05% | 140 |
|
|
2018
Q3 | $427K | Sell |
3,346
-395
| -11% | -$47K | 0.06% | 132 |
|
|
2018
Q2 | $405K | Hold |
3,741
| – | – | 0.06% | 132 |
|
|
2018
Q1 | $396K | Hold |
3,741
| – | – | 0.06% | 132 |
|
|
2017
Q4 | $438K | Hold |
3,741
| – | – | 0.06% | 127 |
|
|
2017
Q3 | $425K | Sell |
3,741
-41
| -1% | -$4.73K | 0.06% | 128 |
|
|
2017
Q2 | $471K | Hold |
3,782
| – | – | 0.07% | 124 |
|
|
2017
Q1 | $448K | Hold |
3,782
| – | – | 0.07% | 125 |
|
|
2016
Q4 | $379K | Hold |
3,782
| – | – | 0.06% | 131 |
|
|
2016
Q3 | $477K | Sell |
3,782
-41
| -1% | -$5.07K | 0.08% | 117 |
|
|
2016
Q2 | $447K | Buy |
3,823
+58
| +2% | +$6.56K | 0.07% | 120 |
|
|
2016
Q1 | $390K | Hold |
3,765
| – | – | 0.07% | 128 |
|
|
2015
Q4 | $375K | Sell |
3,765
-103
| -3% | -$10.1K | 0.07% | 127 |
|
|
2015
Q3 | $353K | Buy |
3,868
+103
| +3% | +$10.3K | 0.07% | 126 |
|
|
2015
Q2 | $399K | Hold |
3,765
| – | – | 0.07% | 124 |
|
|
2015
Q1 | $430K | Hold |
3,765
| – | – | 0.08% | 120 |
|
|
2014
Q4 | $415K | Hold |
3,765
| – | – | 0.07% | 118 |
|
|
2014
Q3 | $368K | Buy |
3,765
+61
| +2% | +$6K | 0.07% | 122 |
|
|
2014
Q2 | $373K | Buy |
3,704
+52
| +1% | +$5.07K | 0.07% | 121 |
|
|
2014
Q1 | $335K | Hold |
3,652
| – | – | 0.06% | 123 |
|
|
2013
Q4 | $330K | Sell |
3,652
-52
| -1% | -$4.5K | 0.06% | 120 |
|
|
2013
Q3 | $295K | Hold |
3,704
| – | – | 0.06% | 126 |
|
|
2013
Q2 | $269K | Buy |
+3,704
| New | +$277K | 0.06% | 128 |
|
Other funds holding ZBH
Kanawha Capital Management's ZBH Position: Q3 2024 in Review
Kanawha Capital Management sold out of Zimmer Biomet (ZBH) in Q3 2024, closing a stake of 2,178 shares — an estimated $236K sold.
Kanawha Capital Management first reported a position in ZBH in Q2 2013 and held it in 44 quarters. The position peaked at $628K in Q2 2021. 981 funds tracked by Wall St. Rank hold ZBH as of Q3 2024.
- Kanawha Capital Management reported no remaining Zimmer Biomet position as of Q3 2024 after selling out during the quarter.
- Kanawha Capital Management sold 2,178 Zimmer Biomet shares in Q3 2024, an estimated $236K.
- Kanawha Capital Management first reported a position in Zimmer Biomet in Q2 2013 and held it in 44 quarters.
- Kanawha Capital Management's Zimmer Biomet position peaked at $628K in Q2 2021.
- 981 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2024.
Based on Kanawha Capital Management's 13F filing for Q3 2024, filed 29 Oct 2024.